DanielJSteinMD

Inflammatory Bowel Disease

Assistant Professor, Medicine, Medical College of Wisconsin

Dr. Stein is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
9200 W Wisconsin Ave
Milwaukee, WI 53226
Phone+1 414-955-6845

Fax+1 414-955-6214

Medical College of Wisconsin Affiliated HospitalsFellowship, Gastroenterology, 2007 - 2010
University of Arizona College of Medicine-TucsonResidency, Internal Medicine, 2003 - 2007
Creighton University School of MedicineClass of 2003

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013

PubMed

Predictive Factors of Non-Inflammatory Small Bowel Obstruction After Bowel Resection in Crohn's Patients.
Mir Zulqarnain, Fouad Jaber, Vinay Jahagirdar, Saqr Alsakarneh, Jose Gomez
Gastroenterology Research. 2024-04-01
1 citations
Outcomes in patients with inflammatory bowel disease and acute gastrointestinal symptoms who test indeterminate for.
Lauren K Johnson, Silvia Munoz-Price, Poonam Beniwal Patel, Amir Patel, Daniel J Stein
Annals of Gastroenterology. 2022-02-14
Serum trough levels of infliximab are not associated with peripheral arthralgia activity in patients with inflammatory bowel disease
Shaina Sekhri, Bharat Rao, Akanksha Mohananey, Poonam Beniwal-Patel, Alexandra Bruss
BMJ Open Gastroenterology. 2021-11-01

Journal Articles

Vedolizumab Concentrations Are Associated with Long-Term Endoscopic Remission in Patients with Inflammatory Bowel Diseases
Ryan Ungaro, Daniel J Stein, Andres J Yarur, Amir Patel, Marla Dubinsky, Digestive Diseases and Sciences

Building Local Expertise: MCW Faculty Join Multi-Institutional Collaborative Partnership to Train Gastroenterologists in RwandaMarch 3rd, 2023